Cover Image
市場調查報告書

C3 Jian, Inc的產品平台分析

C3 Jian, Inc - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321958
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
C3 Jian, Inc的產品平台分析 C3 Jian, Inc - Product Pipeline Review - 2015
出版日期: 2015年04月30日 內容資訊: 英文 28 Pages
簡介

C3 Jian, Inc,是進行人及動物的疾病診斷、治療、預防產品的開發及商品化的生物醫藥品企業。

本報告提供C3 Jian, Inc的治療藥開發平台的各現狀及各開發階段比較分析、各標的、各給藥途徑、各分子類型、各作用機制的治療藥的評估、最近的開發平台趨勢相關資訊等。

C3 Jian, Inc的基本資料

C3 Jian, Inc概要

  • 主要資訊
  • 企業資料

C3 Jian, Inc - Research and Development概要

  • 主要的治療範圍

C3 Jian, Inc:開發平台的檢討

  • 各開發階段的開發中產品
  • 開發中產品:單劑產品

C3 Jian, Inc:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

C3 Jian, Inc:藥物簡介

  • C-16G2
  • 脫髮症及化療的副作用治療的肽
  • 梭孢桿菌屬-難治感染疾病治療的合成肽
  • MRSA感染疾病治療的合成肽
  • 調節骨疾病治療的生物礦物質化的合成肽
  • G-10KHc
  • 蛀牙治療的合成肽

C3 Jian, Inc:開發平台分析

  • 各標的
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

C3 Jian, Inc:最近的開發平台趨勢

C3 Jian, Inc:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07018CDB

Summary

Global Markets Direct's, 'C3 Jian, Inc - Product Pipeline Review - 2015', provides an overview of the C3 Jian, Inc's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of C3 Jian, Inc's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of C3 Jian, Inc including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of C3 Jian, Inc's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the C3 Jian, Inc's pipeline products

Reasons to buy

  • Evaluate C3 Jian, Inc's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of C3 Jian, Inc in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the C3 Jian, Inc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of C3 Jian, Inc and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of C3 Jian, Inc
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of C3 Jian, Inc and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • C3 Jian, Inc Snapshot
    • C3 Jian, Inc Overview
    • Key Information
    • Key Facts
  • C3 Jian, Inc - Research and Development Overview
    • Key Therapeutic Areas
  • C3 Jian, Inc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • C3 Jian, Inc - Pipeline Products Glance
    • C3 Jian, Inc - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • C3 Jian, Inc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • C3 Jian, Inc - Drug Profiles
    • C-16G2
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Peptide for Alopecia and Chemotherapy Effects
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide for Clostridium difficile Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide for MRSA Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide to Modulate Biomineralization for Bone Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptides for Dental Caries
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • C3 Jian, Inc - Pipeline Analysis
    • C3 Jian, Inc - Pipeline Products by Target
    • C3 Jian, Inc - Pipeline Products by Route of Administration
    • C3 Jian, Inc - Pipeline Products by Molecule Type
    • C3 Jian, Inc - Pipeline Products by Mechanism of Action
  • C3 Jian, Inc - Recent Pipeline Updates
  • C3 Jian, Inc - Dormant Projects
  • C3 Jian, Inc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • C3 Jian, Inc, Key Information
  • C3 Jian, Inc, Key Facts
  • C3 Jian, Inc - Pipeline by Indication, 2015
  • C3 Jian, Inc - Pipeline by Stage of Development, 2015
  • C3 Jian, Inc - Monotherapy Products in Pipeline, 2015
  • C3 Jian, Inc - Phase II, 2015
  • C3 Jian, Inc - Preclinical, 2015
  • C3 Jian, Inc - Discovery, 2015
  • C3 Jian, Inc - Pipeline by Target, 2015
  • C3 Jian, Inc - Pipeline by Route of Administration, 2015
  • C3 Jian, Inc - Pipeline by Molecule Type, 2015
  • C3 Jian, Inc - Pipeline Products by Mechanism of Action, 2015
  • C3 Jian, Inc - Recent Pipeline Updates, 2015
  • C3 Jian, Inc - Dormant Developmental Projects,2015
  • C3 Jian, Inc, Subsidiaries

List of Figures

  • C3 Jian, Inc - Pipeline by Top 10 Indication, 2015
  • C3 Jian, Inc - Pipeline by Stage of Development, 2015
  • C3 Jian, Inc - Monotherapy Products in Pipeline, 2015
  • C3 Jian, Inc - Pipeline by Top 10 Route of Administration, 2015
  • C3 Jian, Inc - Pipeline by Top 10 Molecule Type, 2015
Back to Top